Novo Nordisk A/S
NVO | NYSE
$39.83
-$3.41 (-7.89%)
Sep 21, 2026, 11:19 AM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Cash & Equivalents | 26.46B | 15.66B | 14.39B | 12.65B | 10.72B | 2.1B |
Short-Term Investments | 498M | 10.65B | 15.84B | 10.92B | 6.77B | n/a |
Long-Term Investments | 2.51B | 2.68B | 1.66B | 1.34B | 1.44B | 270.9M |
Other Long-Term Assets | 5.86B | 4.02B | 1.43B | 206M | 267M | 110.79M |
Receivables | 75.7B | 87.41B | 75.26B | 57.51B | 46.8B | 4.61B |
Inventory | 49.62B | 40.85B | 31.81B | 24.39B | 19.62B | 3.05B |
Other Current Assets | 20.17B | 6.33B | 2.34B | 9.67B | 1.69B | 1.07B |
Total Current Assets | 172.45B | 160.9B | 139.65B | 108.19B | 85.6B | 10.82B |
Property-Plant & Equipment | 208.38B | 162.49B | 90.96B | 66.67B | 55.36B | 8.26B |
Goodwill & Intangibles | 130.05B | 111.09B | 60.41B | 51.42B | 43.17B | 3.4B |
Total Long-Term Assets | 370.45B | 304.9B | 174.84B | 133.06B | 108.91B | 13B |
Total Assets | 542.9B | 465.8B | 314.49B | 241.26B | 194.51B | 23.82B |
Account Payables | 19.76B | 28.85B | 25.61B | 15.59B | 8.87B | 939.76M |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | 12.02B | 11.78B | 5.3B | 480M | 12.86B | 1.23B |
Other Current Liabilities | 175.47B | 165.85B | 38.14B | 96.8B | 73.3B | 8.74B |
Total Current Liabilities | 215.66B | 217.53B | 169.66B | 120.94B | 99.52B | 11.55B |
Long-Term Debt | 110.37B | 84.25B | 15.98B | 20.78B | 9.65B | n/a |
Other Long-Term Liabilities | 7.64B | 9.68B | 7.58B | 5.45B | 6.01B | 973.95M |
Total Long-Term Liabilities | 133.19B | 104.78B | 38.27B | 36.83B | 24.25B | 1.86B |
Total Liabilities | 348.86B | 322.31B | 207.93B | 157.77B | 123.76B | 13.41B |
Total Debt | 130.96B | 102.79B | 27.01B | 25.78B | 26.65B | 1.7B |
Book Value | 194.05B | 143.49B | 106.56B | 83.49B | 70.75B | 10.41B |
Book Value Per Share | 43.63 | 32.15 | 23.71 | 18.37 | 15.36 | 2.22 |
Common Stock | 446M | 446M | 451M | 456M | 462M | 77.26M |
Retained Earnings | 195.3B | 144.45B | 104.84B | 80.59B | 72B | 10.48B |
Comprehensive Income | -1.7B | -1.41B | 1.28B | 2.45B | -1.71B | -149.75M |
Shareholders Equity | 194.05B | 143.49B | 106.56B | 83.49B | 70.75B | 10.41B |
Total Investments | 3.01B | 13.33B | 17.5B | 12.26B | 8.21B | 270.9M |
Add to Watchlist
Select watchlists to add or remove NVO